2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow SRA737: new trials by email Literature Review of SRA737 trials Research Report on SRA737
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer SRA737 - Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) | Phase 1 / Phase 2 | Completed | Sierra Oncology LLC - a GSK company | 107 | 2016-07-01 | 2023-06-18 |
| A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects SRA737, gemcitabine, cisplatin, SRA737, gemcitabine - Advanced Solid Tumors | Phase 1 / Phase 2 | Completed | Sierra Oncology LLC - a GSK company | 153 | 2016-07-01 | 2023-06-22 |
Fanconi Anemia (2) · Anus Neoplasms (1) · Colorectal Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Sierra Oncology LLC - a GSK company (2)
United Kingdom (2) · Spain (1)